PLx Pharma
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9 Fishers Ln Ste E, Sparta, New Jersey, ...Phone Number
(973) 409-6541Website
www.plxpharma.comRevenue
$10.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About PLx Pharma
PLx Pharma Inc. is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with certain drugs.Explore more
PLx Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PLx Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PLx Pharma had a recent Job posting/layoffs
PLx Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at PLx Pharma
Earning: See what the market has to say on PLx Pharma recently announced quarterly report
Check if PLx Pharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when PLx Pharma launches new products
Funding: Get notified immidiatlly once PLx Pharma has new funding data
Check out if PLx Pharma is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined PLx Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to PLx Pharma
Compare insights from companies similar to PLx Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PLx Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PLx Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PLx Pharma.
PLx Pharma financials insights
Gather financial insights about PLx Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$1.3M
2020
Share Placement
$8M
PLx Pharma Tech Stack
A closer look at the technologies used by PLx Pharma
Most Recent Scoops
Earnings
Event
Earnings, Events
Earnings
PLx Pharma has reported revenues of $1.59 million for the period ending on 12/31/2021, missing expectations of $2.05 million.
Earnings
Earnings
PLx Pharma has reported revenues of $6.60 million for the period ending on 9/30/2021, beating expectations of $4.10 million.
Earnings
Funding
PLx Pharma News & Media
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses. The Company today announced that it entered into a stalking horse asset purchase agreement (the “APA”) with PLx Acquisition Company, LLC, a wholly-owned subsidiaryPLx Pharma (PLXP) Q3 2022 Earnings Call Transcript
PLx Pharma Inc. (NASDAQ:NASDAQ:PLXP) Q3 2022 Earnings Conference Call November 11, 2022 8:30 am ET Company Participants Natasha Giordano - President, Chief Executive Officer Rita O’Connor -...Earnings Preview: PLx Pharma
PLx Pharma (NASDAQ:PLXP) is set to give its latest quarterly earnings report on Friday, 2022-11-11. Here's what investors need to know before the announcement. Analysts estimate that PLx Pharma will report an earnings per share (EPS) of $-0.44. read moreBaseball Legend John Smoltz Featured on PLx Pharma’s Social Channels
Legendary Baseball Pitcher and Avid Golfer Uses VAZALORE® 325 mg for Fast, Effective Pain Relief Legendary Baseball Pitcher and Avid Golfer Uses VAZALORE® 325 mg for Fast, Effective Pain Relief
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PLx Pharma
Sign Up For FreeTo access detailed company insights
PLx Pharma Inc. is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. P... Read More
